Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024 -33341.2% Operating margin3 -1.9% Revenue growth, 20243 Where the money goes Where each dollar of revenue went, fiscal 2024 Research and development Income tax
Research and development 53¢ $400.0K Income tax 47¢ $356.0K Out of $308.0K in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 6 3 $308.0K in 20240 $10.0M $20.0M $30.0M 2020: $0 $0 2020 2021: $20.4M $20.4M 2021 2022: $233.0K $233.0K 2022 −99% 2023: $314.0K $314.0K 2023 +35% 2024: $308.0K $308.0K 2024 −2% Operating income4 5 6 3 -$102.7M in 2024−1% since 2020 -$150.0M -$100.0M -$50.0M 0 2020: -$104.2M -$104.2M 2020 2021: -$135.8M -$135.8M 2021 +30% 2022: -$144.8M -$144.8M 2022 +7% 2023: -$125.5M -$125.5M 2023 −13% 2024: -$102.7M -$102.7M 2024 −18% Net income4 5 6 3 -$149.3M in 2024−12% since 2020 -$200.0M -$150.0M -$100.0M -$50.0M 0 2020: -$169.8M -$169.8M 2020 2021: -$167.8M -$167.8M 2021 −1% 2022: -$152.4M -$152.4M 2022 −9% 2023: -$40.2M -$40.2M 2023 −74% 2024: -$149.3M -$149.3M 2024 +271% Revenue7 8 9 $749.0K in Q3 FY2025−52% since Q1 FY2025 0 $500.0K $1.0M $1.5M $2.0M Q1 FY2025: $1.6M $1.6M Q1 FY2025 Q2 FY2025: $719.0K $719.0K Q2 FY2025 −54% Q3 FY2025: $749.0K $749.0K Q3 FY2025 +4% Operating income7 8 9 -$28.4M in Q3 FY2025+40% since Q1 FY2025 -$30.0M -$20.0M -$10.0M 0 Q1 FY2025: -$20.4M -$20.4M Q1 FY2025 Q2 FY2025: -$25.3M -$25.3M Q2 FY2025 +24% Q3 FY2025: -$28.4M -$28.4M Q3 FY2025 +13% Net income7 8 9 -$61.1M in Q3 FY2025+131% since Q1 FY2025 -$80.0M -$60.0M -$40.0M -$20.0M 0 Q1 FY2025: -$26.4M -$26.4M Q1 FY2025 Q2 FY2025: -$27.7M -$27.7M Q2 FY2025 +5% Q3 FY2025: -$61.1M -$61.1M Q3 FY2025 +120% Fiscal year 2019 2020 2021 2022 2023 2024 Revenue $04 $20.4M5 $233.0K6 $314.0K3 $308.0K3 Research and development $2.8M6 $2.0M3 $400.0K3 Operating income -$104.2M4 -$135.8M5 -$144.8M6 -$125.5M3 -$102.7M3 Interest $923.0K6 $2.7M6 Income tax $305.0K4 $4.0M5 $6.2M6 $1.0M3 -$356.0K3 Net income -$169.8M4 -$167.8M5 -$152.4M6 -$40.2M3 -$149.3M3 Earnings per share -$1.215 -$0.986 -$0.253 -$0.933 Earnings per share (diluted) -$1.215 -$0.986 -$0.253 -$0.933
Total assets4 5 6 3 $159.4M in 2024+43% since 2020 0 $200.0M $400.0M $600.0M 2020: $111.5M $111.5M 2020 2021: $414.2M $414.2M 2021 +271% 2022: $305.4M $305.4M 2022 −26% 2023: $293.5M $293.5M 2023 −4% 2024: $159.4M $159.4M 2024 −46% Total liabilities4 5 6 3 $42.8M in 2024+165% since 2020 0 $20.0M $40.0M $60.0M 2020: $16.2M $16.2M 2020 2021: $28.2M $28.2M 2021 +74% 2022: $39.7M $39.7M 2022 +41% 2023: $49.2M $49.2M 2023 +24% 2024: $42.8M $42.8M 2024 −13% Shareholders’ equity4 5 6 3 $116.3M in 2024+28% since 2020 0 $100.0M $200.0M $300.0M $400.0M 2020: $90.8M $90.8M 2020 2021: $376.9M $376.9M 2021 +315% 2022: $260.7M $260.7M 2022 −31% 2023: $243.0M $243.0M 2023 −7% 2024: $116.3M $116.3M 2024 −52% Cash4 5 6 3 $17.5M in 2024−42% since 2019 0 $100.0M $200.0M $300.0M $400.0M 2019: $30.1M $30.1M 2019 2020: $97.2M $97.2M 2020 +223% 2021: $362.3M $362.3M 2021 +273% 2022: $190.6M $190.6M 2022 −47% 2023: $45.0M $45.0M 2023 −76% 2024: $17.5M $17.5M 2024 −61% Long-term debt5 6 3 $14.1M in 20240 $5.0M $10.0M $15.0M $20.0M 2021: $0 $0 2021 2022: $14.7M $14.7M 2022 2023: $15.0M $15.0M 2023 +2% 2024: $14.1M $14.1M 2024 −6% Total assets8 9 7 $239.8M in Q3 FY2025+50% since Q2 FY2024 0 $100.0M $200.0M $300.0M Q2 FY2024: $159.4M $159.4M Q2 FY2024 Q3 FY2024: $159.4M $159.4M Q3 FY2024 +0% Q1 FY2025: $195.8M $195.8M Q1 FY2025 +23% Q2 FY2025: $189.2M $189.2M Q2 FY2025 −3% Q3 FY2025: $239.8M $239.8M Q3 FY2025 +27% Total liabilities8 9 7 $79.9M in Q3 FY2025+87% since Q2 FY2024 0 $20.0M $40.0M $60.0M $80.0M Q2 FY2024: $42.8M $42.8M Q2 FY2024 Q3 FY2024: $42.8M $42.8M Q3 FY2024 +0% Q1 FY2025: $43.5M $43.5M Q1 FY2025 +2% Q2 FY2025: $45.3M $45.3M Q2 FY2025 +4% Q3 FY2025: $79.9M $79.9M Q3 FY2025 +76% Shareholders’ equity8 9 7 $159.8M in Q3 FY2025+37% since Q2 FY2024 0 $50.0M $100.0M $150.0M $200.0M Q2 FY2024: $116.3M $116.3M Q2 FY2024 Q3 FY2024: $116.3M $116.3M Q3 FY2024 +0% Q1 FY2025: $152.1M $152.1M Q1 FY2025 +31% Q2 FY2025: $143.7M $143.7M Q2 FY2025 −5% Q3 FY2025: $159.8M $159.8M Q3 FY2025 +11% Cash8 9 7 $30.4M in Q3 FY2025+74% since Q2 FY2024 0 $20.0M $40.0M $60.0M $80.0M Q2 FY2024: $17.5M $17.5M Q2 FY2024 Q3 FY2024: $17.5M $17.5M Q3 FY2024 +0% Q1 FY2025: $48.3M $48.3M Q1 FY2025 +176% Q2 FY2025: $61.9M $61.9M Q2 FY2025 +28% Q3 FY2025: $30.4M $30.4M Q3 FY2025 −51% Long-term debt8 9 7 $0 in Q3 FY20250 $5.0M $10.0M $15.0M Q2 FY2024: $14.1M $14.1M Q2 FY2024 Q3 FY2024: $14.1M $14.1M Q3 FY2024 +0% Q1 FY2025: $9.3M $9.3M Q1 FY2025 −34% Q2 FY2025: $0 $0 Q2 FY2025 Q3 FY2025: $0 $0 Q3 FY2025 Fiscal year 2019 2020 2021 2022 2023 2024 Cash $30.1M4 $97.2M4 $362.3M5 $190.6M6 $45.0M3 $17.5M3 Current assets $99.5M4 $375.1M5 $287.1M6 $185.6M3 $80.1M3 Total assets $111.5M4 $414.2M5 $305.4M6 $293.5M3 $159.4M3 Current liabilities $12.3M4 $20.9M5 $19.9M6 $20.1M3 $25.0M3 Long-term debt $05 $14.7M6 $15.0M3 $14.1M3 Total liabilities $16.2M4 $28.2M5 $39.7M6 $49.2M3 $42.8M3 Shareholders’ equity $90.8M4 $376.9M5 $260.7M6 $243.0M3 $116.3M3 Shares outstanding 114.7M shares4 160.7M shares5 165.9M shares6 166.0M shares3 168.0M shares3
Cash from operations4 5 6 3 -$82.4M in 2024+297% since 2020 -$150.0M -$100.0M -$50.0M 0 2020: -$20.8M -$20.8M 2020 2021: -$63.2M -$63.2M 2021 +205% 2022: -$104.5M -$104.5M 2022 +65% 2023: -$84.1M -$84.1M 2023 −19% 2024: -$82.4M -$82.4M 2024 −2% Capital spending4 5 6 3 $6.0K in 2024−90% since 2020 0 $200.0K $400.0K $600.0K $800.0K 2020: $59.0K $59.0K 2020 2021: $173.0K $173.0K 2021 +193% 2022: $773.0K $773.0K 2022 +347% 2023: $259.0K $259.0K 2023 −66% 2024: $6.0K $6.0K 2024 −98% Free cash flow4 5 6 3 -$82.4M in 2024+296% since 2020 -$150.0M -$100.0M -$50.0M 0 2020: -$20.8M -$20.8M 2020 2021: -$63.4M -$63.4M 2021 +205% 2022: -$105.2M -$105.2M 2022 +66% 2023: -$84.4M -$84.4M 2023 −20% 2024: -$82.4M -$82.4M 2024 −2% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2019 2020 2021 2022 2023 2024 Cash from operations -$20.8M4 -$63.2M5 -$104.5M6 -$84.1M3 -$82.4M3 Capital spending $59.0K4 $173.0K5 $773.0K6 $259.0K3 $6.0K3 Free cash flow -$20.8M -$63.4M -$105.2M -$84.4M -$82.4M Share buybacks $500.0K4
Compare Atai Beckley N.V. with another company
Former names
ATAI Life Sciences N.V. Mar 4, 2021 to Nov 5, 20252 ATAI Life Sciences B.V. Feb 1, 2021 to Jun 21, 20212
Recent filings
Dec 5, 2025 8-K Nov 26, 2025 4 Nov 12, 2025 8-K Nov 12, 2025 10-Q Nov 6, 2025 3 Nov 6, 2025 3 Nov 6, 2025 4 Nov 6, 2025 4 Nov 6, 2025 4 Nov 5, 2025 8-K Nov 5, 2025 8-K Nov 4, 2025 8-K Oct 27, 2025 8-K Oct 21, 2025 8-K Oct 20, 2025 8-K Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
